Profound Medical Corp.

NASDAQ:PROF

8.2 (USD) • At close September 6, 2024
Bedrijfsnaam Profound Medical Corp.
Symbool PROF
Munteenheid USD
Prijs 8.2
Beurswaarde 200,750,760
Dividendpercentage 0%
52-weken bereik 7.11 - 11.69
Industrie Medical Devices
Sector Healthcare
CEO Dr. Arun Swarup Menawat MBA, Ph.D.
Website https://www.profoundmedical.com

An error occurred while fetching data.

Over Profound Medical Corp.

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging

Vergelijkbare Aandelen

Talkspace, Inc. logo

Talkspace, Inc.

TALK

1.79 USD

Fusion Pharmaceuticals Inc. logo

Fusion Pharmaceuticals Inc.

FUSN

21.55 USD

Beyond Air, Inc. logo

Beyond Air, Inc.

XAIR

0.41 USD

Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc.

RYTM

49.25 USD

XBiotech Inc. logo

XBiotech Inc.

XBIT

6.52 USD

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

6.13 USD

Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ

0.327 USD

Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc.

VKTX

54.13 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)